Riboxxim

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRiboxxim
Drug Alias NameApoxximRIBOXXIMRIBOXXONRGC-1RGC-L2 +[7] 
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionToll like receptor 3 agonistsRetinoic acid-inducible gene I modulators
TargetsToll like receptor 3Retinoic acid-inducible gene I
Therapy Area/IndicationsVirus Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRiboxx Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesTollys SasRiboxx Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsVirus Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A